New class of biphenylene dibenzazocinones as potent ligands for the human EP1 prostanoid receptor.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  1999-09-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0960-894X(99)00465-5PMID 10509919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors.

  1999cited by this paper
• Chapter 22 - Prostanoid Receptors

  1998cited by this paper
• Molecular aspects of the structures and functions of the prostaglandin E receptors.

  1996cited by this paper
• Aminoacetyl moiety as a potential surrogate for diacylhydrazine group of SC-51089, a potent PGE2 antagonist, and its analogs.

  1996cited by this paper
• Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*)

  1995cited by this paper
• 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid,2-[3-[2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC-51322): A potent PGE2 antagonist and analgesic

  1994cited by this paper
• Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.

  1994cited by this paper
• Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype.

  1994cited by this paper
• Cloning and expression of a cDNA for the human prostanoid IP receptor.

  1994cited by this paper
• Cloning and expression of three isoforms of the human EP3 prostanoid receptor

  1994cited by this paper
• Cloning and expression of a cDNA for the human prostanoid FP receptor.

  1994cited by this paper
• Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.

  1993cited by this paper
• N-substituted dibenzoxazepines as analgesic PGE2 antagonists.

  1993cited by this paper
• Cloning and expression of cDNA for a human thromboxane A2 receptor

  1991cited by this paper
• The Palladium-Catalyzed Cross-Coupling Reaction of Phenylboronic Acid with Haloarenes in the Presence of Bases

  1981cited by this paper

• Prostanoid receptors in GtoPdb v.2025.3

  2025cites this paper
• Prostanoid receptors in GtoPdb v.2021.2

  2021cites this paper
• Prostaglandin E2 receptors and their role in gastrointestinal motility - potential therapeutic targets.

  2020cites this paper
• Nitrogen Bridged Diazocines: Photochromes Switching within the Near-Infrared Region with High Quantum Yields in Organic Solvents and in Water.

  2019cites this paper
• Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Structural features of subtype-selective EP receptor modulators.

  2017cites this paper
• Insertion Reactions on Carbopalladated Benzyne: From Eight- to Nine- and Ten-Membered Palladacycles. Applications to the Synthesis of N-Heterocycles

  2014cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

  2011cites this paper
• Agents Acting on Prostanoid and Thromboxane Receptors

  2010cites this paper
• Prostanoid receptor antagonists: development strategies and therapeutic applications

  2009cites this paper
• EP-1 Prostanoid Receptor

  2008cites this paper
• Physiology and pathophysiology of prostanoid receptors.

  2007cites this paper
• Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists.

  2007cites this paper
• EP1 antagonists for the treatment of inflammatory pain.

  2007cites this paper
• Physiology and pathophysiology of prostanoid receptors

  2007cites this paper
• Synthesis of highly substituted dibenzo[b,f]azocines and their evaluation as protein kinase inhibitors.

  2006cites this paper
• Discovery of new chemical leads for selective EP1 receptor antagonists.

  2006cites this paper
• Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.

  2006cites this paper
• 2,3-Diarylthiophenes as selective EP1 receptor antagonists.

  2005cites this paper
• Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonists.

  2005cites this paper
• Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques

  2002cites this paper
• The design and synthesis of selective prostaglandin analogs as bone anabolic agents for the potential treatment of osteoporosis.

  2002cites this paper
• Physiological and Pathophysiological Roles of Prostanoids; Lessons from Receptor-Knockout Mice for Clinical Applications

  2001cites this paper
• Novel EP receptor ligands

  2000cites this paper
• The synthesis and human FP receptor binding affinity of 13,14-dihydro prostaglandin F1alpha sulfonamides: potential treatments for osteoporosis.

  2000cites this paper
• Expert Opinion on Therapeutic Patents

  1998cites this paper